12.5: Manufacturing Quality and Contamination Prevention

Quality and Regulatory Compliance in Bioscience · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-SA 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    12.5: Manufacturing Quality and Contamination Prevention

    For an approved medicine, every new batch must meet the applicable quality requirements. U.S. current good manufacturing practice (cGMP) requirements for finishedPrevent, validate, verify clean manufacturing.png pharmaceuticals are found in 21 CFR Parts 210 and 211. Other rules can apply depending on the product and the activity. FDA guidance explains the agency’s current thinking and can help manufacturers decide how to meet applicable requirements.

    Drug contamination can arise from raw materials, equipment, water, people, packaging, or the manufacturing environment. Examples include unwanted particles, microorganisms, residues from other products, and endotoxins. Endotoxins are components of Gram-negative bacterial outer membranes; not all production organisms make them. A product may also be legally adulterated because of inadequate manufacturing controls even when a specific contaminant has not been detected.

    Contamination prevention works best as a set of connected controls. Purchasing staff communicate material requirements and use approved suppliers. Receiving staff check shipment identity, condition, and handling information. Production staff follow cleaning and operating procedures. Laboratory staff use suitable methods, and quality personnel review evidence before material or product is released.

    Imagine that a supplier changes the manufacturing site for an ingredient. A familiar product name does not establish that the new source has the same risks. The manufacturer should evaluate the change through its approved system, including relevant supplier information, material characteristics, and any additional testing or qualification needed. This is a hypothetical example of prevention through communication and oversight.

    Cross-contamination can occur when residue from one product reaches another. A cleaning program therefore needs justified limits, suitable sampling, and methods capable of finding relevant residues. A clean appearance can be useful information, but it cannot establish that invisible chemical or microbial residues are adequately controlled.

    Cleaning validation demonstrates that a defined cleaning process can consistently remove residues to justified limits. A sound program considers product carryover, cleaning-agent residues, microbial risks, equipment design, sampling, and analytical method suitability. Cleaning verification checks individual cleaning events; it is not identical to validating the process.

    Ingredient adulteration risk guide.pngDocumented Example Melamine and Supplier Risk

    Melamine is a nitrogen-rich industrial chemical used in products such as resins and plastics. It is different from cyanuric acid. When added fraudulently to certain food ingredients, it can make nonspecific nitrogen tests suggest a higher protein content. Exposure to contaminated products has caused serious kidney injury. Melamine and cyanuric acid together can form crystals that damage the kidneys.

    FDA guidance on pharmaceutical components at risk for melamine contamination recommends evaluating the supply chain and appropriately testing at-risk components. The lesson for quality assurance is broader than a single chemical: manufacturers must understand raw-material risks and use tests that can detect relevant adulteration. 


    This page titled 12.5: Manufacturing Quality and Contamination Prevention was last modified on Sun, 08 Nov 2026 14:23:41 GMT and is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by Emalee MacKenzie.